FOLR1 TRAILBody (Trio Pharmaceuticals)

N/A

Report date: 2024/08/21 11:18:02

Base Information

Drug NameFOLR1 TRAILBody (Trio Pharmaceuticals)
Drug Alias NameTRIO 628TRIO-628
ClassificationBiologics
Mechanisms of ActionFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsEndometrial NeoplasmsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTRIO Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTRIO Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A